scholarly journals Long-term detection of atrial fibrillation with insertable cardiac monitors in a real-world cryptogenic stroke population

2017 ◽  
Vol 244 ◽  
pp. 175-179 ◽  
Author(s):  
Paul D. Ziegler ◽  
John D. Rogers ◽  
Scott W. Ferreira ◽  
Allan J. Nichols ◽  
Mark Richards ◽  
...  
2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
P.D Ziegler ◽  
J.D Rogers ◽  
M Richards ◽  
A.J Nichols ◽  
S.W Ferreira ◽  
...  

Abstract Background/Introduction The primary goal of monitoring for atrial fibrillation (AF) after cryptogenic stroke (CS) is secondary stroke prevention. Therefore, long-term monitoring of CS patients with insertable cardiac monitors (ICMs) is likely important to ensure appropriate secondary stroke prevention therapy, regardless of when AF is detected after the index event. However, long-term data on the incidence and duration of AF from real-world populations are sparse. Purpose To investigate the long-term incidence and duration of AF episodes in real-world clinical practice among a large population of patients with ICMs placed for AF detection following CS. Methods We included patients from a large device manufacturer's database who received an ICM for the purpose of AF detection following CS and were monitored for up to 3 years. All detected AF episodes (≥2 minutes) were adjudicated. We quantified the AF detection rate for various episode duration thresholds using Kaplan-Meier survival estimates, analyzed the maximum duration of AF episodes, and measured the time to initial AF detection. Results A total of 1247 patients (65.3±13.0 years, 53% male) were included and followed for 763±362 days. AF episodes (n=5456) were detected in 257 patients, resulting in a median frequency of 5 episodes [IQR 2–19] per patient. At 3 years, the AF detection rate for episodes ≥2 minutes was 24.2%. The AF detection rates at 3 years for episodes ≥6 minutes, ≥30 minutes, and ≥1 hour were 22.4%, 20.6%, and 19.1%, respectively. The median duration of the longest detected AF episode was 4.4 [IQR 1.2–13.9] hours and the median time to AF detection was 129 [IQR 45–354] days. Conclusion AF episodes were detected via ICMs in approximately one-quarter of CS patients within 3 years of follow-up. More than 75% of patients with AF detected had episodes lasting ≥1 hour and half had episodes lasting ≥4 hours. Detection of the first AF episode typically occurred beyond the range of conventional ambulatory monitors. Long-term surveillance of CS patients is likely important given the appreciable incidence, frequency, and duration of these AF episodes. Funding Acknowledgement Type of funding source: None


Circulation ◽  
2020 ◽  
Vol 142 (Suppl_3) ◽  
Author(s):  
Naga Venkata K Pothineni ◽  
Uyanga Batnyam ◽  
Jeffrey Arkles ◽  
John Bullinga ◽  
Brett L CUCCHIARA ◽  
...  

Introduction: Long-term monitoring for atrial fibrillation (AF) is recommended in patients, who have experienced a cryptogenic stroke (CS). Clinical trials have identified AF in ~30% of patients after 3 years of continuous monitoring with insertable cardiac monitors (ICMs). Hypothesis: In a real-world analysis from a large academic healthcare system, we sought to evaluate a CS population with ICMs and a) determine the yield of AF and subsequent initiation of anticoagulation; and b) identify the presence of other arrhythmias. Methods: We evaluated all CS patients who had received an ICM between October 2014 and April 2020. We manually reviewed all stored electrocardiograms that were automatically labeled as AF by the ICM and adjudicated them as either a) AF or b) other cardiac arrhythmia including premature atrial contractions (PAC), premature ventricular contractions (PVC), supraventricular tachycardia (SVT), or nonsustained ventricular tachycardia (NSVT). Results: A total of 84 CS patients with ICMs were included: 51% men, mean age 63 years, and mean CHA 2 DS 2 -VASc 4.1. Over a median follow-up duration of 15.7 months, there were 34 patients (40% of the cohort) who did not have any AF alerts. In the remaining 50 patients, there were 960 stored electrograms that were adjudicated. Only 154 recordings from 16 patients (19% of the entire cohort) were adjudicated as AF. Oral anticoagulation was initiated in all these patients with adjudicated AF. The remaining tracings, which had been automatically categorized by the ICM as AF alerts, represented 34 patients (40% of the cohort). These patients had other arrhythmias including frequent PACs or PVCs, SVT, or NSVT. Conclusions: Compared to clinical trials, our real-world assessment suggests that the yield of AF following CS is lower - approximately 20%. Our findings highlight the importance for reviewing device tracings given the high rates of false positive for AF. Further research to refine AF detection algorithms in ICMs is needed.


2011 ◽  
Vol 2011 ◽  
pp. 1-5 ◽  
Author(s):  
Archit Bhatt ◽  
Arshad Majid ◽  
Anmar Razak ◽  
Mounzer Kassab ◽  
Syed Hussain ◽  
...  

Background and Purpose. Paroxysmal Atrial fibrillation/Flutter (PAF) detection rates in cryptogenic strokes have been variable. We sought to determine the percentage of patients with cryptogenic stroke who had PAF on prolonged non-invasive cardiac monitoring.Methods and Results. Sixty-two consecutive patients with stroke and TIA in a single center with a mean age of 61 (+/− 14) years were analyzed. PAF was detected in 15 (24%) patients. Only one patient reported symptoms of shortness of breath during the episode of PAF while on monitoring, and 71 (97%) of these 73 episodes were asymptomatic. A regression analysis revealed that the presence of PVCs (ventricular premature beats) lasting more than 2 minutes (OR 6.3, 95% CI, 1.11–18.92;P=.042) and strokes (high signal on Diffusion Weighted Imaging) (OR 4.3, 95% CI, 5–36.3;P=.041) predicted PAF. Patients with multiple DWI signals were more likely than solitary signals to have PAF (OR 11.1, 95% CI, 2.5–48.5,P<.01).Conclusion. Occult PAF is common in cryptogenic strokes, and is often asymptomatic. Our data suggests that up to one in five patients with suspected cryptogenic strokes and TIAs have PAF, especially if they have PVCs and multiple high DWI signals on MRI.


2019 ◽  
Vol 15 (4) ◽  
pp. 545
Author(s):  
Jin-Man Jung ◽  
Yong-Hyun Kim ◽  
Sungwook Yu ◽  
Kyungmi O ◽  
Chi Kyung Kim ◽  
...  

Stroke ◽  
2015 ◽  
Vol 46 (suppl_1) ◽  
Author(s):  
Judith C Lenane ◽  
Angela J Fought ◽  
Jay H Alexander

Introduction: Long term ECG monitoring to detect atrial fibrillation in a cryptogenic stroke is now the emerging standard of care. The advent of patch based ECG monitors raises the question of patient compliance with this new modality. Hypothesis: We assessed the hypothesis that patient compliance, as measured by Leads-On detection for patch based ECG monitoring, is constant over time. Methods: We performed a retrospective analysis from ZIO® Patch (Patch) devices (iRhythm, San Francisco, CA). The Patch is a continuous recording single lead ECG monitor that can be worn for up to 14 days. The primary endpoint of Leads-On is the percentage of time the device is applied to the patient during the wear period, which was derived from a second channel in the device. The data are gathered by ZEUS software and exported in a CSV file. The compliance data were analyzed overall and in categories at days: 0-1, 1-2, 2 to 7, >7 to 10 and >10 to 14. A secondary endpoint, percent Analyzable Time (percentage of ECG record that was available for detection by the algorithm during the wear period and signifies signal quality), was assessed for the same time increments. Results: The dataset consisted of 18,885 records. The total wear time ranged from 0.10 up to 14.01 days, with a median of 12.51. The medians and interquartile ranges for the percent Leads On and percent of Analyzable Time were 100% (99.99-100%) and 97.99% (94.64-99.26%). In Table 1, the interquartile ranges for percent Leads On and Analyzable Time was wider when the Patch was worn less than a day, but remains above 74%. Total wear time in days n Percent Leads On Percent Analyzable Time Median Interquartile Range Median Interquartile Range 0.10-<1 105 99.65 86.52-100 92.86 74.19-96.97 1-<2 407 100 99.88-100 97.37 90.96-99.02 2-<7 4124 100 100-100 97.96 94.3-99.26 7-<10 2963 100 99.98-100 97.79 94.33-99.19 10+ 11286 100 100-100 98.07 95.00-99.29 Conclusion: Patient compliance with long term ECG patch monitors is high as measured by Leads-On detection. High patient compliance results in a large volume of quality ECG. Further study is needed to compare patient compliance with ECG patch based monitors with other monitoring modalities, particularly in the cryptogenic stroke population.


2020 ◽  
Vol 75 (11) ◽  
pp. 497
Author(s):  
Michael Riordan ◽  
Ayhan Yoruk ◽  
Arwa Younis ◽  
Adil Ali ◽  
Amanda Opaskar ◽  
...  

2021 ◽  
Author(s):  
Peng Zhang ◽  
Fan Lin ◽  
Fei Ma ◽  
Yuting Chen ◽  
Daowen Wang ◽  
...  

SummaryBackgroundWith the increasing demand for atrial fibrillation (AF) screening, clinicians spend a significant amount of time in identifying the AF signals from massive electrocardiogram (ECG) data in long-term dynamic ECG monitoring. In this study, we aim to reduce clinicians’ workload and promote AF screening by using artificial intelligence (AI) to automatically detect AF episodes and identify AF patients in 24 h Holter recording.MethodsWe used a total of 22 979 Holter recordings (24 h) from 22 757 adult patients and established accurate annotations for AF by cardiologists. First, a randomized clinical cohort of 3 000 recordings (1 500 AF and 1 500 non-AF) from 3000 patients recorded between April 2012 and May 2020 was collected and randomly divided into training, validation and test sets (10:1:4). Then, a deep-learning-based AI model was developed to automatically detect AF episode using RR intervals and was tested with the test set. Based on AF episode detection results, AF patients were automatically identified by using a criterion of at least one AF episode of 6 min or longer. Finally, the clinical effectiveness of the model was verified with an independent real-world test set including 19 979 recordings (1 006 AF and 18 973 non-AF) from 19 757 consecutive patients recorded between June 2020 and January 2021.FindingsOur model achieved high performance for AF episode detection in both test sets (sensitivity: 0.992 and 0.972; specificity: 0.997 and 0.997, respectively). It also achieved high performance for AF patient identification in both test sets (sensitivity:0.993 and 0.994; specificity: 0.990 and 0.973, respectively). Moreover, it obtained superior and consistent performance in an external public database.InterpretationOur AI model can automatically identify AF in long-term ECG recording with high accuracy. This cost-effective strategy may promote AF screening by improving diagnostic effectiveness and reducing clinical workload.Research in contextEvidence before this studyWe searched Google Scholar and PubMed for research articles on artificial intelligence-based diagnosis of atrial fibrillation (AF) published in English between Jan 1, 2016 and Aug 1, 2021, using the search terms “deep learning” OR “deep neural network” OR “machine learning” OR “artificial intelligence” AND “atrial fibrillation”. We found that most of the previous deep learning models in AF detection were trained and validated on benchmark datasets (such as the PhysioNet database, the Massachusetts Institute of Technology Beth Israel Hospital AF database or Long-Term AF database), in which there were less than 100 patients or the recordings contained only short ECG segments (30-60s). Our search did not identify any articles that explored deep neural networks for AF detection in large real-world dataset of 24 h Holter recording, nor did we find articles that can automatically identify patients with AF in 24 h Holter recording.Added value of this studyFirst, long-term Holter monitoring is the main method of AF screening, however, most previous studies of automatic AF detection mainly tested on short ECG recordings. This work focused on 24 h Holter recording data and achieved high accuracy in detecting AF episodes. Second, AF episodes detection did not automatically transform to AF patient identification in 24 h Holter recording, since at present, there is no well-recognized criterion for automatically identifying AF patient. Therefore, we established a criterion to identify AF patients by use of at least one AF episode of 6 min or longer, as this condition led to significantly increased risk of thromboembolism. Using this criterion, our method identified AF patients with high accuracy. Finally, and more importantly, our model was trained on a randomized clinical dataset and tested on an independent real-world clinical dataset to show great potential in clinical application. We did not exclude rare or special cases in the real-world dataset so as not to inflate our AF detection performance. To the best of our knowledge, this is the first study to automatically identifies both AF episodes and AF patients in 24 h Holter recording of large real-world clinical dataset.Implications of all the available evidenceOur deep learning model automatically identified AF patient with high accuracy in 24 h Holter recording and was verified in real-world data, therefore, it can be embedded into the Holter analysis system and deployed at the clinical level to assist the decision making of Holter analysis system and clinicians. This approach can help improve the efficiency of AF screening and reduce the cost for AF diagnosis. In addition, our RR-interval-based model achieved comparable or better performance than the raw-ECG-based method, and can be widely applied to medical devices that can collect heartbeat information, including not only the multi-lead and single-lead Holter devices, but also other wearable devices that can reliably measure the heartbeat signals.


Stroke ◽  
2016 ◽  
Vol 47 (suppl_1) ◽  
Author(s):  
Mark Richards ◽  
John D Rogers ◽  
Scott W Ferreira ◽  
Allan J Nichols ◽  
Jodi L Koehler ◽  
...  

Introduction: Detection of atrial fibrillation (AF) in patients with a cryptogenic stroke (CS) is critical for reducing the risk of recurrent stroke by enabling oral anticoagulation therapy. However, the impact of age on AF detection and the optimum duration of AF monitoring in patients following a CS is not well characterized. We investigated the impact of age on AF detection among a large, real-world cohort of unselected patients with an implantable cardiac monitor (ICM) placed following CS. Methods: Patients in the de-identified Medtronic Discovery™ Link database who received an ICM (Reveal LINQ™) for AF detection following CS were included and monitored for up to 182 days. All AF episodes were adjudicated. We compared the mean age between patients with vs. without AF detected and compared the median time to detection of the first AF episode between younger (age ≤65) and older (age >65) patients. Results: Among 1247 patients (mean age 65.3±13.0, 53% male) followed for 182 [IQR 182-182] days, 1521 AF episodes were detected in 147 patients and resulted in an AF detection rate of 12.2%. Patients with AF detected were significantly older than patients without AF detected (71.3±10.9 vs. 64.5±13.1 years, respectively; p<0.001). The median time to detection of the first AF episode was shorter for older vs. younger patients (43 [10-91] vs. 89 [29-127] days, respectively; p=0.016; Figure). Conclusion: Continuous monitoring of CS patients with an ICM resulted in an AF detection rate of 12.2% within the initial 6 months. Patients with AF detected were older and patients >65 years of age had shorter times to initial AF detection. However even among older patients, the majority of AF occurred outside the range of external monitoring devices and thus highlights the importance of long-term monitoring with ICMs in the management of CS patients.


F1000Research ◽  
2016 ◽  
Vol 5 ◽  
pp. 168 ◽  
Author(s):  
Cen Zhang ◽  
Scott Kasner

Despite many advances in our understanding of ischemic stroke, cryptogenic strokes (those that do not have a determined etiology) remain a diagnostic and therapeutic challenge. Previous classification approaches to cryptogenic stroke have led to inconsistent definitions, and evidence to determine optimal treatment is scarce. These limitations have prompted international efforts to redefine cryptogenic strokes, leading to more rigorous diagnostic criteria, outcome studies, and new clinical trials. Improvement in our ability to detect paroxysmal atrial fibrillation in patients with cryptogenic stroke has strengthened the idea that these strokes are embolic in nature. Further, better understanding of acute biomarkers has helped to identify otherwise occult mechanisms. Together, these strategies will inform long-term outcomes and shape management.


Sign in / Sign up

Export Citation Format

Share Document